» Articles » PMID: 31320741

Systematic Review of Somatic Mutations in Splenic Marginal Zone Lymphoma

Overview
Journal Sci Rep
Specialty Science
Date 2019 Jul 20
PMID 31320741
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The aims of this systematic review are to refine the catalogue of somatic variants in splenic marginal zone lymphoma (SMZL) and to provide a well-annotated, manually curated database of high-confidence somatic mutations to facilitate variant interpretation for further biological studies and future clinical implementation. Two independent reviewers systematically searched PubMed and Ovid in January 2019 and included studies that sequenced SMZL cases with confirmed diagnosis. The database included fourteen studies, comprising 2817 variants in over 1000 genes from 475 cases. We confirmed the high prevalence of NOTCH2, KLF2 and TP53 mutations and analysis of targeted genes further implicated TNFAIP3, KMT2D, and TRAF3 as recurrent targets of somatic mutation based on their high incidence across studies. The major limitations we encountered were the low number of patients with whole-genome, unbiased analysis and the relative sensitivities of differing sequencing approaches. Overall, we showed that there is little concordance between whole exome sequencing studies of SMZL. We strongly support the continuing unbiased analysis of the SMZL genome for mutations in all protein-coding genes and provide a valuable database resource to facilitate this endeavour that will ultimately improve our understanding of SMZL pathobiology.

Citing Articles

Molecular Mechanisms in the Transformation from Indolent to Aggressive B Cell Malignancies.

Maher N, Mouhssine S, Matti B, Alwan A, Gaidano G Cancers (Basel). 2025; 17(5).

PMID: 40075754 PMC: 11899122. DOI: 10.3390/cancers17050907.


Clinicopathological characteristics and genomic profiling in patients with transformed lymphoma: a monocentric retrospective study.

Zhao X, Bian H, Hao F, Shao S, Wu C, Zhang Q Ann Med. 2024; 56(1):2419556.

PMID: 39460552 PMC: 11514389. DOI: 10.1080/07853890.2024.2419556.


Splenic marginal zone lymphoma with prolymphocytic transformation and cyclin D1 expression in the absence of CCND1 rearrangement.

Elbaz Younes I, Bunting S, Zhang X Int J Hematol. 2024; 120(6):750-754.

PMID: 39285033 DOI: 10.1007/s12185-024-03845-6.


The genomic and molecular landscape of splenic marginal zone lymphoma, biological and clinical implications.

Mirandari A, Parker H, Ashton-Key M, Stevens B, Walewska R, Stamatopoulos K Explor Target Antitumor Ther. 2024; 5(4):877-901.

PMID: 39280243 PMC: 11390296. DOI: 10.37349/etat.2024.00253.


The many faces of nodal and splenic marginal zone lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.

Zamo A, Brand M, Climent F, de Leval L, Dirnhofer S, Leoncini L Virchows Arch. 2023; 483(3):317-331.

PMID: 37656249 PMC: 10542713. DOI: 10.1007/s00428-023-03633-3.


References
1.
Martinez N, Almaraz C, Vaque J, Varela I, Derdak S, Beltran S . Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation. Leukemia. 2013; 28(6):1334-40. DOI: 10.1038/leu.2013.365. View

2.
Wang K, Zhang Q, Li D, Ching K, Zhang C, Zheng X . PEST domain mutations in Notch receptors comprise an oncogenic driver segment in triple-negative breast cancer sensitive to a γ-secretase inhibitor. Clin Cancer Res. 2015; 21(6):1487-96. DOI: 10.1158/1078-0432.CCR-14-1348. View

3.
Peveling-Oberhag J, Wolters F, Doring C, Walter D, Sellmann L, Scholtysik R . Whole exome sequencing of microdissected splenic marginal zone lymphoma: a study to discover novel tumor-specific mutations. BMC Cancer. 2015; 15:773. PMC: 4619476. DOI: 10.1186/s12885-015-1766-z. View

4.
Wang K, Li M, Hakonarson H . ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010; 38(16):e164. PMC: 2938201. DOI: 10.1093/nar/gkq603. View

5.
Xochelli A, Oscier D, Stamatopoulos K . Clonal B-cell lymphocytosis of marginal zone origin. Best Pract Res Clin Haematol. 2017; 30(1-2):77-83. DOI: 10.1016/j.beha.2016.08.028. View